The LDN Shop
Visit our e-commerce website for Conferences, Webinars, Medical Membership, eBooks etc
Join our community here.
Dr Brian Udell on Low Dose Naltrexone, LDN Radio Show 17 May 2017 (LDN, low dose naltrexone) from LDN Research Trust on Vimeo.
Today our guest would be Dr. Brian Udell who is the medical director of the Child Development Center of America in Florida.
Linda Elsegood: Thank you for joining us today Dr. Brian Udell!
Cheryl - US: Lyme Disease (LDN, low dose naltrexone) from LDN Research Trust on Vimeo.
Cheryl from the United States takes LDN for Lyme disease and Co infections.
Her story goes back into childhood. She had always struggled with some sort of illnesses. Gastrointestinal issues, stomach virus, rashes on her face, etc
Brittany - US: Multiple Sclerosis (MS) (LDN, low dose naltrexone) from LDN Research Trust on Vimeo.
Linda Elsegood: I would like to introduce Brittany from the United States who takes LDN for Vasculitis and Multiple Sclerosis. Thanks for joining me, Brittany.
Brittany: Thank you.
Anne (2) - England: Multiple Sclerosis (MS) (LDN, low dose naltrexone) from LDN Research Trust on Vimeo.
Linda Elsegood: like to introduce Anne from England who takes LDN for multiple sclerosis. Good morning
Anne (England): Good morning.
Alan - England: Multiple Sclerosis; MS (LDN, low dose naltrexone) from LDN Research Trust on Vimeo.
Linda: I would like to introduce Alan from England. Alan has multiple sclerosis.
Alan: Hello. Could you tell us when you first started getting ms symptoms?
A Comparison of Medication-Assisted Treatment Options for Opioid Addiction: A Review of the Literature
J Addict Nurs
30 June 2021
https://pubmed.ncbi.nlm.nih.gov/34224485/
Opioid receptor system contributes to the acute and sustained antidepressant-like effects, but not the hyperactivity motor effects of ketamine in mice
Pharmacol Biochem Behav
02 July 2021
https://pubmed.ncbi.nlm.nih.gov/34224734/
Psychopharmacologic Therapies for Irritable Bowel Syndrome (Abstract)
Gastroenterol Clin North Am
Epub 01 July 2021
https://pubmed.ncbi.nlm.nih.gov/34304793/
Reported Benefits of Low-Dose Naltrexone Appear to Be Independent of the Endogenous Opioid System Involving Proopiomelanocortin Neurons and β-Endorphin
eNeuro
126 June 2021
https://pubmed.ncbi.nlm.nih.gov/34031099/